Clinical Trials Browser

Phase 2 × Unknown × Lymphoma, T-Cell, Peripheral × Clear all

NCT05976997 2023-08-04

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04480099 2023-06-13

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT05495100 2022-08-10

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT03629873 2022-01-03

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04052659 2021-03-09

Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT03502629 2021-03-03

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04457830 2020-10-22

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04329130 2020-04-24

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02495415 2019-07-23

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02753543 2017-11-14

Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT03321890 2017-10-26

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT02944812 2016-10-26

Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02856997 2016-08-05

Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT02404571 2016-07-26

GDP in Frontline Chemotherapy for Patients With PTCL-NOS

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral

NCT01016990 2014-01-10

Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

Phase 2 Unknown

DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01307592 2014-01-10

Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00840385 2010-09-15

FAD

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00974324 2010-09-15

PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00299351 2006-03-06

A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral